Susquehanna Fundamental Investments’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
Susquehanna Fundamental Investments's GILD Position: Q1 2026 in Review
Susquehanna Fundamental Investments sold out of Gilead Sciences (GILD) in Q1 2026, closing a stake of 33,179 shares — an estimated $4.07M sold.
Susquehanna Fundamental Investments first reported a position in GILD in Q1 2018 and held it in 21 quarters. The position peaked at $30.4M in Q1 2025. 2,320 funds tracked by Wall St. Rank hold GILD as of Q1 2026.
- Susquehanna Fundamental Investments reported no remaining Gilead Sciences position as of Q1 2026 after selling out during the quarter.
- Susquehanna Fundamental Investments sold 33,179 Gilead Sciences shares in Q1 2026, an estimated $4.07M.
- Susquehanna Fundamental Investments first reported a position in Gilead Sciences in Q1 2018 and held it in 21 quarters.
- Susquehanna Fundamental Investments's Gilead Sciences position peaked at $30.4M in Q1 2025.
- 2,320 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.
Based on Susquehanna Fundamental Investments's 13F filing for Q1 2026, filed 15 May 2026.